Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Comment by alixx11on Sep 01, 2010 11:24am

342 Views

Post# 17404048

RE: RE: RE: Time for a breakout

I still go back to what I wrote a week or so ago :

While they might have been planning to release some news in September, the sudden by-in by Aurizon had changed the plan. There is now a major drilling program in place that wasn't on the table before ARZ came around in July. Anything that NOX was planning to do before that, well just forget about it. If they had anything they were plainning to announce, they'll wait and combine it with the first results to come from this new drill program.

And remember, the new drill program starts in September, so no news for awhile after that...

Still one of my favorites long term (but my fingers are crossed for the nest results, whenever that is...)

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario